Forst_2010_Diabet.Med_27_1409

Reference

Title : Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes - Forst_2010_Diabet.Med_27_1409
Author(s) : Forst T , Uhlig-Laske B , Ring A , Graefe-Mody U , Friedrich C , Herbach K , Woerle HJ , Dugi KA
Ref : Diabet Med , 27 :1409 , 2010
Abstract : Forst_2010_Diabet.Med_27_1409
ESTHER : Forst_2010_Diabet.Med_27_1409
PubMedSearch : Forst_2010_Diabet.Med_27_1409
PubMedID: 21059094

Related information

Citations formats

Forst T, Uhlig-Laske B, Ring A, Graefe-Mody U, Friedrich C, Herbach K, Woerle HJ, Dugi KA (2010)
Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes
Diabet Med 27 :1409

Forst T, Uhlig-Laske B, Ring A, Graefe-Mody U, Friedrich C, Herbach K, Woerle HJ, Dugi KA (2010)
Diabet Med 27 :1409